Kwang-Hoe Chung

Title: Kwang-Hoe Chung: Innovator in Monoclonal Antibody Research

Introduction

Kwang-Hoe Chung is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of five patents to his name, Chung's work has the potential to impact medical diagnostics and treatment.

Latest Patents

Chung's latest patents include a monoclonal antibody against D-dimer and methods of use therefor. This invention discloses a monoclonal antibody produced in a mouse that specifically targets human D-dimer and high molecular weight cross-linked fibrin. The antibody can be effectively used as a diagnostic agent for screening and detecting in-vivo D-dimer and its derivatives. The invention emphasizes that the monoclonal antibody does not bind to human fibrinogen or fibrin, making it a valuable tool in medical diagnostics.

Career Highlights

Throughout his career, Kwang-Hoe Chung has worked at notable institutions, including Mogam Biotechnology Research Institute. His research has focused on the development of innovative diagnostic tools that can enhance patient care and treatment outcomes.

Collaborations

Chung has collaborated with several professionals in his field, including Doo-Sik Kim and Sung-Yu Hong. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Kwang-Hoe Chung is a distinguished inventor whose work in monoclonal antibody research holds promise for improving diagnostic methods in medicine. His contributions continue to influence the field and pave the way for future innovations.